Osmotic drug delivery systems: Basics and design approaches

Recent Patents on Drug Delivery and Formulation

Volumn 7, Issue 2, 2013, Pages 150-161

  Patra, Chinam N ^a   Swain, Suryakanta ^a   Sruti, Jammula ^a   Patro, Allupati P ^a   Panigrahi, Kahnu C ^a   Beg, Sarwar ^a   Rao, Muddana E B ^a  

^a Roland Institute of Pharmaceutical Science   (India)

Author keywords

Controlled drug delivery; Formulation factors; Osmotic devices; Osmotic pressure; Patents

Indexed keywords

NIFEDIPINE;

CONTROLLED POROSITY OSMOTIC PUMP; DRUG BIOAVAILABILITY; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; DRUG SAFETY; DRUG SOLUBILITY; ELEMENTARY OSMOTIC PUMP; MEMBRANE PERMEABILITY; OSMOTIC BURSTING PUMP; OSMOTIC DRUG DELIVERY SYSTEM; OSMOTIC PRESSURE; OSMOTIC PUMP; PATENT; PRIORITY JOURNAL; PULSATILE DRUG RELEASE; PUSH PULL OSMOTIC PUMP; REVIEW;

DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; OSMOTIC PRESSURE; PATENTS AS TOPIC; PHARMACEUTICAL PREPARATIONS; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL;

EID: 84880150594     PISSN: 18722113     EISSN: None     Source Type: Journal    
DOI: 10.2174/1872211311307020007     Document Type: Review

References (89)

1. Prescott LF. In: Prescott LF, Nimmo WS, Eds. Novel drug delivery and its therapeutic application. New York: John Wiley 1989: 1-11.
2. Sastry SV, DeGennaro MD, Reddy IK, Khan MA. Atenolol gastrointestinal therapeutic system 1. Screening of formulation variables. Drug Dev Ind Pharm 1997; 23: 157-65.
3. Verma RK, Krishna DM, Garg S. Formulation aspects in development of osmotically controlled oral drug delivery systems. J Control Release 2002; 79: 7-27.
4. Theeuwes FD, Swanson R, Guittard G, Ayer A, Khanna S. Osmotic delivery systems for the, 3-adrenoceptor antagonists metoprolol and oxprenolol: design and evaluation of systems for oncedaily administration. Br J Clin Pharmacol 1985; 19: 69S-76S.
5. Eckenhoff B, Yum SI. The osmotic pump novel research tool for optimizing drug regimens. Biomaterials 1981; 2: 89-97.
6. Bindschaedler C, Gurny R, Doelker E. Osmotically controlled drug delivery systems produced from organic solutions and aqueous dispersions of cellulose acetate. J Control Release 1986; 4: 203-12.
7. Sareen R, Jain N, Kumar D. An insight to osmotic drug delivery. Curr Drug Deliv 2012; 9: 285-96.
8. N. Ramakrishna N, Mishra B. Design and evaluation of osmotic pump tablets of naproxen sodium. Pharmazie 2001; 56: 958-62.
9. Jerzewski RL, Chien YW. In: A. Kydonieus, Eds. Treatise on controlled drug delivery: Fundamentals, optimization, applications. New York: Marcel Dekker 1992; 225-53.
10. McClelland GA, Sutton SC, Engle K, Zentner GM. Solubility modulated osmotic pump: In vitro/in vivo release of diltiazem hydrochloride. Pharm Res 1991; 8: 88-92.
11. Kumar P, Singh S, Mishra B. Development and evaluation of elementary osmotic pump of highly water soluble drug: tramadol hydrochloride. Curr Drug Deliv 2009; 6: 130-9.
12. Appel LE, Zentner GM. Use of modified ethylcellulose lattices for microporous coating of osmotic tablets. Pharm Res 1991; 8: 600-4.
13. Langer RS, Paepps NA. Present and future applications of biomaterials in controlled drug delivery system. Biomaterials 1981; 2: 201-14.
14. Park SJ, Kim KS, Kim SH. Effect of poly (ethylene oxide) on the release behaviors of poly (€-caprolactone) microcapsules containing erythromycin. Colloids Surf Biointerfaces 2005; 43: 238-44.
15. Khanna, S.C. Therapeutic system for sparingly soluble active ingredients. US4992278 (1991).
16. Theeuwes, F. Osmotic dispenser with gas generating means. US4036228 (1977).
17. Krogel I, Bodmeier R. Floating or pulsatile drug delivery systems based on coated effervescent cores. Int J Pharm 1999; 187: 175-84.
18. S. Sotthivirat S, J.L.Haslam JL, Stella VJ. Controlled porosityosmotic pump pellets of a poorly water-soluble drug using sulfobutylether-β-cyclodextrin, (SBE)7M-β-CD, as a solubilizing and osmotic agent. J Pharm Sci 2007; 96: 2364-74.
19. Okimoto K, Rajewski RA, Stella VJ. Release of testosterone from an osmotic pump tablet utilizing (SBE)-7m-β-CD as both solubilizing and an osmotic pump agent. J Control Release 1999; 58: 29-38.
20. Okimoto K, Ohike A, Ibuki R, Aoki O, Ohnishi N, Irie T, et al. Design and evaluation of osmotic pump tablet (OPT) for chlorpromazine using (SBE)-7m-β-CD. Pharm Res 1999; 16: 549-54.
21. Gan Y, Pan W, Wei M, Ahang R. Cyclodextrin complex osmotic tablet for glipizide delivery. Drug Dev Ind Pharm 2002; 28: 1015-21.
22. Liu X, Chen D, Zhang R. Evaluation of monolithic osmotic tablet system for nifedipine delivery in vitro and in vivo. Drug Dev Ind Pharm 2003; 29: 813-19.
23. Huanhuan C, Guoqiang J, Fuxin D. Monolithic osmotic tablet containing solid dispersion of 10-hydroxycamptothecin. Drug Dev Ind Pharm 2009; 35: 131-7.
24. Liu L, Wang X. Solubility-modulated monolithic osmotic pump tablet for atenolol delivery. Eur J Pharm Biopharm 2008; 68: 298-302.
25. Pinto JF. Site-specific drug delivery systems within the gastrointestinal tract from the mouth to the colon. Int J Pharm 2010; 395: 44-52.
26. Chauhan CS, Choudhury PK. Controlled porosity osmotic pump for the delivery of flurbiprofen. Curr Drug Deliv 2006; 3: 193-98.
27. Rudnic, E.M., Burnside, B.A., Flanner, H.H., Wassink, S.E., Couch, R.A., Pinkett, J.E. Osmotic drug delivery system. US6110498 (2000).
28. Lu EX, Jiang ZQ, Zhang QZ, Jiang XU. A water insoluble drug monolithic osmotic tablet utilizing gum Arabic as an osmotic, suspending and expanding agent. J Control Release 2003; 92: 375-82.
29. Gupta BP, Thakur N, Jain NP, Banweer J, Jain S. Osmotically controlled drug delivery system with associated drugs. J Pharm Pharm Sci 2010; 13:571-88.
30. Cortese, R., Theeuwes, F. Osmotic device with hydrogel driving member. US4327725 (1982).
31. Rajeshri W, Bajaj A. Once a day osmotic drug delivery system for highly water soluble Pramipexole. J Chem Pharm Res 2010; 2: 136-46.
32. Edavalath S, Shivanand K, Prakasam K, Rao BP, Divakar G. Formulation development and optimization of controlled porosity osmotic pump tablets of Diclofenac Sodium. Int J Pharm Sci 2011; 3: 80-7.
33. Vemula SK, Veerareddy PR. Different approaches to design and evaluation of colon specific drug delivery systems. Int J Pharm Sci Drug Res 2009; 1: 1-35.
34. Jain AK, Jain CP. Effect of Superdisintegrating agent and osmogens on Ciprofloxacin loaded naturally occurring biodegradable coated tablets for colon targeting. Int J Pharm Sci 2010; 2: 160-5.
35. Heng PW, Hao J, Chan LW, Chew SH. Influences of osmotic agents in diffusion layer on drug release from multilayer coated pellets. Drug Dev Ind Pharm 2004; 30: 213-20.
36. Punitha S, Shirisha G. Formulation and evaluation of porous osmotic pump based release system of oxybutynin. Int J Pharm Tech Res. 2010; 2: 1723-32.
37. Guarve K, Gupta GD. Development and in vitro evaluation of osmotically controlled oral drug delivery system of carvedilol. Int J Pharm Sci Drug Res 2009; 1: 80-2.
38. Devesh K, Anil S, Vipin S, Singh BV, Chauhan CS. Formulation and characterization of osmotically controlled release system of valsartan. J Sci Spec Res 2010; 1: 39-44.
39. Yang L, Fassihi R. Examination of drug solubility, polymer types, hydrodynamics and loading dose on drug release behavior from a triple-layer asymmetric configuration delivery system. Int J Pharm 1997; 155: 219-29.
40. Ozdemir N, Sahin J. Design of a controlled release osmotic pump system of ibuprofen. Int J Pharm 1997; 158: 91-7.
41. Liu H, Yang XG, Nie SF, Wei LL, Zhoub L, Liu H, et al. Chitosanbased controlled porosity osmotic pump for colon-specific delivery system: Screening of formulation variables and in vitro investigation. Int J Pharm 2007; 332: 115-24.
42. Kumar P, Mishra B. Studies on elementary osmotic tablets of naproxen sodium. Acta Pharm Turcica 2004; 46: 35-41.
43. Samani SM, Adrangui M, Shadbad MRS, Nokhodchi A. An approach to controlled release dosage form of propranolol hydrochloride. Drug Dev Ind Pharm 2000; 26: 91-4.
44. Gaebler F. Laser drilling enables advanced drug delivery systems. In: Coherent article for pharm manufacturing. Control Micro Syst 2007; 21: 1-7.
45. Ayer AD., Balki, HH. Method and apparatus for forming a hole in a drug dispensing device. US5071607 (1991).
46. Shivanand P, Sprockel OL. A controlled porosity drug delivery system. Int J Pharm. 1998; 167: 83-96.
47. Kanagale P, Lohray BB, Misra A, Davadra P, Kini R. Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin. AAPS PharmSci Tech 2007; 8: E13-E19.
48. Zentner GM, Rork GS, Himmelstein KJ. Osmotic flow through controlled porosity films: An approach to delivery of water soluble compounds. J Control Release 1985; 2: 217-29.
49. Theeuwes F. Elementary osmotic pump. J Pharm Sci 1975; 64: 1987-91.
50. Shanbhag A, Barclay B, Koziara J, Shivanand P. Application of cellulose acetate butyrate-based membrane for osmotic drug delivery. Cellulose 2007; 14: 65-71.
51. Baker RW. In: Baker RW Eds. Controlled release of biologically active agents. New York: John Wiley and Sons 1987: 132-55.
52. Ramakrishna N, Mishra B. Plasticizer effect and comparative evaluation of cellulose acetate and ethylcellulose-HPMC combination coatings as semipermeable membranes for oral osmotic pumps of Naproxen sodium. Drug Dev Ind Pharm 2002; 28: 403-12.
53. Catellani PL, Colombo P, Peppas NA, Santi P, Bettini R. Partial permselective coating adds an osmotic contribution to drug release from swellable matrixes. J Pharm Sci 1998; 87: 726-31.
54. Ravishankar H, Patil P, Samel A, Petereit HU, Lizio R. Controlled release by permeability alteration of cationic ammonio methacrylate copolymers using ionic interactions, Drug Dev Ind Pharm. 2006; 32: 709-18.
55. Razaghi AM, Schwartz JB. Investigation of cyclobenzaprine hydrochloride release from oral osmotic delivery systems containing a water-swellable polymer. Drug Dev Ind Pharm 2002; 28: 631-9.
56. Rose S, Nelson JF. A continuous long-term injector. Aust J Exp Biol 1955; 33: 415-20.
57. Higuchi, T.H., Leeper, M. Improved osmotic dispenser employing magnesium sulfate and magnesium chloride. US7608041973 (2013).
58. Barbara G, Stubbe SC, Smedt D, Demeester J. Programmed polymeric devices for pulsed drug delivery. Pharm Res 2004; 21: 1732-40.
59. Higuchi, T., Leeper, H.M. Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient. US3995631 (1976).
60. Verma RK, Mishra B, Garg S. Osmotically controlled oral drug delivery. Drug Dev Ind Pharm 2000; 26: 695-708.
61. Rani M, Surana R, Sankar C, Mishra B. Development and biopharmaceutical evaluation of osmotic pump tablets for controlled delivery of diclofenac sodium. Acta Pharm 2003; 53: 263-73.
62. Prabakaran D, Singh P, Kanaujia P, Jaganathan KS, Rawat A, Vyas SP. Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization. Int J Pharm 2004; 284: 95-108.
63. Wong, P.S.I., Barclay, B., Deters, J.C., Theeuwes, F. Osmotic device with dual thermodynamic activity. US4612008 (1986).
64. Bhatt PP. Osmotic drug delivery systems for poorly soluble drugs. Technology/Industry overviews. The drug delivery comparison report. 2004; Autumn/winter: 26-9.
65. Thombre AG, Appel LE, Chidlaw MB, Daugherity PD, Dumont F, Evans LAF, et al. Osmotic drug delivery using swellable-core technology. J Control Release 2004; 94: 75-89.
66. Thombre AG, Zenter GM, Himmelistein KJ. Mechanism of water transport in controlled porosity osmotic devices. J Memb Sci 1989: 40: 279-310.
67. Malaterrea V, Ogorkaa J, Loggiaa N, Gurny R. Approach to design push-pull osmotic pumps. Int J Pharm 2009; 376: 56-62.
68. Anschutz M, Wonnemann M, Schug B, Toal C, Donath F, Pontius A, et al. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration. Int J Clin Pharmacol Ther 2010; 48:158-70.
69. Makhija SN, Vavia PR. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine: I. Cellulose acetate as a semi permeable membrane. J Control Release 2003; 89: 5-18.
70. Ueda S, Asakura TS, Yamaguchi H, Kotani M, Veda Y. Development of a novel drug release system, time controlled explosion system (TES) concept and design. J Drug Target 1994; 2:35-44.
71. Li S, Liu R, Nuo W. In: Liu R, Eds. Oral modified release drug delivery for water insoluble drugs. New Jersy: CRC-Press 2008: 623-36.
72. Dollery CT. Pharmacological basis for combination therapy of hypertension. Annu Rev Pharmacol Toxicol 1977; 17:311-23.
73. Liu L, Ku J, Khana G, Lee B, Rhee JM, Lee HB. Nifedipine controlled delivery by sandwiched osmotic tablet system. J. Control Release 2000; 68:145-56.
74. Kumarvelrajan R, Narayana N, Suba V, Bhaskar K. Simultanious delivery of nifedipine and metoprolol tartarate using sandwiched osmotic pump tablet system. Int J Pharm 2010; 399: 60.
75. Panda RR, Tiwary AK. Hot melt granulation: a facile approach for monolithic osmotic release tablets. Drug Dev Ind Pharm 2012; 38: 447-61.
76. Dharmadhikari, N.B.M., Ashish, P. Oral osmotic controlled drug delivery system. US20030219485 (2003).
77. Viswanathan, N.B.S., Ramakrishnan, V., Rajan, K.R., Rajeev S.R., Ashok, K. Mono compartment osmotic controlled drug delivery system. WO2003092660 (2005).
78. Wong, P.L.S., Theeuwes, F., Guittard, G.V., Ayer, A.D. Osmotic caplet. US6773721 (2004).
79. Harper, D.J., Milo, C.F. Osmotic pump drug delivery systems and methods. US6471688 (2003).
80. Anderson, R.C. Osmotic intraosseous drug delivery system. US20070005043 (2007).
81. Michaels, AS. Guillod, MS. Osmotic bursting drug delivery device. US4177256 (1979).
82. Viswanathan, N.B., Sankar, R., Verma, R.K., Raghuvanshi, R.S., Rampal, A.K. Monocompartment osmotic controlled drug delivery system. WO2003092660 (2003).
83. Lautenbach, S.D. Minimally compliant, volume-efficient piston for osmotic drug delivery systems. US7112335 (2006).
84. Peterson, L.L., Maruyama, F.H., Dehnad, H.H., Lawton, L., Kevin, S., Davis, C.R., Peery, J.R. Osmotic delivery system flow modulator apparatus and method. US7407500 (2005).
85. Faour, J. Combined diffusion/osmotic pumping drug delivery system. US6352721 (2002).
86. Puthli, S.P., Menon, S.G., Karajgi, J.S., Dharmadhikari, N.B., Shrivastava, R.H., Pilgaonkar, P.S. Oral osmotic controlled drug delivery system for a sparingly soluble drug. US6534090 (2003).
87. Anderson, R.C., Osmotic intraosseous drug delivery system. WO2007005680A1 (2006).
88. Theeuwes, F.E. Osmotic delivery system having space efficient piston. US6544252 (2003).
89. Dionne, K.E., Lautenbach, S.D., Eftimie, A.C., Kevin, L.Y. S. Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems. EP1066081 (2003).